Compare GAUZ & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GAUZ | POM |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Other Specialty Stores |
| Sector | Miscellaneous | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 7.1M |
| IPO Year | 2019 | 2021 |
| Metric | GAUZ | POM |
|---|---|---|
| Price | $0.39 | $0.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 11.9M | 37.8K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.59 | N/A |
| Revenue Next Year | $59.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.06 |
| 52 Week High | $7.07 | $6.43 |
| Indicator | GAUZ | POM |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 45.85 |
| Support Level | $0.36 | $0.85 |
| Resistance Level | $0.50 | $1.17 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 51.23 | 9.25 |
Gauzy Ltd is a fully integrated light and vision control company. Its products products include suspended particle device, or SPD, and liquid crystal, or LC, materials for smart glass applications, and AI-powered advanced driver assistance systems, or ADAS, solutions including camera monitoring systems, or CMS. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.